Low-inflammatory lipid nanoparticle-based mRNA vaccine elicits protective immunity against H5N1 influenza virus with reduced adverse reactions
2024 · Molecular Therapy · 28 citations
https://doi.org/10.1016/j.ymthe.2024.12.032
Kyoto University(JP)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
10
Papers
54
Citations
3
h-index
3
i10-index
Taro Shimizu is an academic researcher from Kyoto University. The author has contributed to research in topics: Clinical Reasoning and Diagnostic Skills & Innovations in Medical Education & Medical Malpractice and Liability Issues. The author has an h-index of 3, co-authored 9 publications.
https://doi.org/10.1016/j.ymthe.2024.12.032
https://doi.org/10.1016/j.ecoinf.2025.103009
https://doi.org/10.7759/cureus.89294
Click to start Chat